Literature DB >> 24796236

Prognostic markers of sarcoidosis: an analysis of patients from everyday pneumological practice.

Martina Doubková1, Zdeněk Pospíšil2, Jana Skřičková1, Michael Doubek3.   

Abstract

INTRODUCTION: Although sarcoidosis is a well-known disease, sarcoidosis patient outcome and the role of prognostic markers in everyday practice have not yet been well described. Therefore, the goal of the present study was to analyse the fate of sarcoidosis patients and the factors influencing the disease's behaviour in routine practice.
METHODS: The study was a retrospective analysis of 306 consecutive patients (181 females and 125 males; median age 45 years) diagnosed with sarcoidosis in the years 2003-2012.
RESULTS: Through the use of uniparametric analysis, it was determined that the stage of the disease, organ involvement, CD4/CD8 ratio in the bronchoalveolar lavage fluid (BALF), serum and urine calcium levels, smoking, and pulmonary functions had a significant influence on spontaneous sarcoidosis resolution. Multiparametric analysis revealed that spontaneous resolution was significantly positively influenced by female gender, a less advanced disease stage, a higher CD4/CD8 ratio in the BALF, lymphocytosis in the BALF and normal pulmonary functions at diagnosis. During follow-up, only three patients died. The causes of death were respiratory failure with pneumonia (n = 2) and heart attack caused by sarcoidosis heart involvement (n = 1).
CONCLUSION: The data show sarcoidosis as a disorder with high variability in clinical and laboratory findings but with good general prognosis.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  diagnosis; prognostic factors; sarcoidosis; therapy

Mesh:

Year:  2014        PMID: 24796236     DOI: 10.1111/crj.12160

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  4 in total

1.  Bronchoalveolar lavage characteristics correlate with HLA tag SNPs in patients with Löfgren's syndrome and other sarcoidosis.

Authors:  B Karakaya; M C Schimmelpennink; L Kocourkova; J J van der Vis; B Meek; J C Grutters; M Petrek; C H M van Moorsel
Journal:  Clin Exp Immunol       Date:  2019-01-24       Impact factor: 4.330

2.  Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: A single center real-world study.

Authors:  Chuling Fang; Qian Zhang; Na Wang; Xiaoyan Jing; Zuojun Xu
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

3.  Prognostic features of sarcoidosis course in a Brazilian cohort.

Authors:  Marina Dornfeld Cunha Castro; Carlos Alberto de Castro Pereira; Maria Raquel Soares
Journal:  J Bras Pneumol       Date:  2022-02-02       Impact factor: 2.624

4.  Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility.

Authors:  Paolo Cameli; Carla Caffarelli; Rosa Metella Refini; Laura Bergantini; Miriana d'Alessandro; Martina Armati; Maria Dea Tomai Pitinca; Piersante Sestini; Stefano Gonnelli; Elena Bargagli
Journal:  Front Med (Lausanne)       Date:  2020-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.